Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
31.58
+0.35 (1.12%)
At close: Apr 24, 2026, 4:00 PM EDT
32.05
+0.47 (1.49%)
After-hours: Apr 24, 2026, 7:59 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.39 billion as of April 24, 2026. Its market cap has increased by 157.76% in one year.
Market Cap
3.39B
Enterprise Value
2.86B
1-Year Change
157.76%
Ranking
Category
Stock Price
$31.58
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.39B, an increase of 345.11%. That is a compound annual growth rate of 34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 3.39B | 28.95% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 3.74B |
| Tango Therapeutics | 3.72B |
| Telix Pharmaceuticals | 3.61B |
| Oruka Therapeutics | 3.47B |
| NewAmsterdam Pharma Company | 3.42B |
| Catalyst Pharmaceuticals | 3.34B |
| Structure Therapeutics | 3.22B |
| Arcus Biosciences | 3.20B |